|
If you are having trouble viewing this email click
here to view it online. |
||
Research
Office Newsletter
|
||
|
May
2007 |
||
Links
|
News
|
Dates
|
|
-
Office of Sponsored Research |
From the Director of the RO |
For more information on upcoming dates
see the RO Calendar. 8th June 2007 |
From the Office of Sponsored Research
|
||
From the Office
of Research Integrity
|
||
From the Office of Commercialisation
|
||
From the Director of the ROThe College Research Managers met on
22 May. This group is focused on the
broad range of research Management activities including Commercialisation;
Research Integrity; Research Management Data and Sponsored Research. It provides the opportunity for the
College's senior research management staff to meet with myself and the
Research Office section heads. The
next meeting is scheduled for 26 June. The Research Office has received
many comments over the last few weeks about the utility of its website. We are about to embark on a process of
reviewing our site based on the needs of our users, including new OoC pages, revamping the OSR and ORI pages as well as
establishing pages specifically for ORMD.
In the coming weeks you will be asked to provide your views on how the
RO website can be changed to make it more useful for you and to fit in with
College RO websites. |
||
From the Office of Sponsored Research
New Travel Grants The
Vice-Chancellor has agreed to make available $500,000 per year in 2007, 2008
and 2009 to support visits to the University by academics with exceptional
records and the capacity to add value to ANU. All members of ANU academic
staff are eligible to submit applications to sponsor visitors. Visitors to
ANU under this program must normally reside outside Funding is provided under this
program on the basis that it is in addition to existing funding programs. Any
academic area reducing its current support for visiting academics will be
ineligible to seek funding under this program for a period of 12 months. The sponsoring academic must submit
a brief report (150 words maximum) on the activities undertaken by the
visitor during the visit and confirm that at least one public lecture,
community lecture and master class have been given. The grants can also be
used to support research collaborations and to enable new/junior staff to
establish research partnerships. Applications will be accepted at any
time during the year. See ANU
website for more information http://info.anu.edu.au/OVC/Policy_and_Planning/Travel_Grants/index.asp Nominations for appointments to positions on
the ARC College of Experts that will become vacant at the end of 2007 close
with the ARC on 13
June 2007. The Researchers who are considering nominating
for the position must read the documentation thoroughly and are strongly
encouraged to talk with relevant ARC Executive Director. All relevant information can also be found on
the ARC web site at http://www.arc.gov.au/about_arc/expert.htm Sheikh Hamdan
Bin Rashid Al Maktoum Awards for Medical Sciences The Sheikh Hamdan
Bin Rashid Al Maktoum Awards for Medical Sciences
were established in 1999 by His Highness Sheikh Hamdan
Bin Rashid Al Maktoum, Deputy Ruler of Grand Hamdan
International Award
For
research in the area of Stem Cell Research. Hamdan
Award for Medical Research Excellence
For research in the areas of -
Therapy in
Malignancy -
Molecular
Therapy in Drug Targeting (Pharmacogenomics) -
Organ Tissue Transplantation 3
winners each receiving US 27,000 each Due: November 30th 2007 |
||
From the Office of Research Integrity
Changes to the NH&MRC National
Statement on Ethical Conduct NH&MRC have recently released
the National Statement on Ethical Conduct in Human Research, replacing the
1999 National Statement. Whilst the
framework for ethical consideration remains essentially unchanged in the new
version there are many changes in relation to particular issues and
emphases. The new National Statement
also allows a more flexible approach to ethical review. Within the terms of the National
Statement, Aboriginal and Torres Strait Islander people studies and clinical
trials must undergo full ethical review by the HREC. The following fields of research are
subject to full HREC review, except where the research uses collection of
non-identifiable data and involves negligible risk and may be exempted from
review: Human genetics, human stem cells, woman who are pregnant and the
human foetus, people highly dependent on medical
care who may be unable to give consent, people with cognitive impairment, an
intellectual disability, or a mental illness, and people who may be involved
in illegal activities. Negligible risk is where there is no
foreseeable risk of harm or discomfort; and any foreseeable risk is no more
than inconvenience. By
contrast research is low risk where the only foreseeable risk is one of
discomfort. It has been determined
that research exempted from review will need to be recorded through the E1
processes in the new ANU system. The new National Statement calls for
the minimisation of duplication of ethical review. Within the new system for human research
ethics at ANU a protocol previously approved by a HREC outside ANU will be
processed through the E1 (Low-risk protocols) process outlined in the last RO
Newsletter. A low-risk protocol will normally be approved within 5 working
days of submission. |
||
From
the Office of Commercialisation
The Attorney-General's Department
released information recently about a new Statement of IP Principles which
all government agencies will be required to comply with by July 1, 2008.
Although there currently exists National Principles of IP Management for
Publicly Funded Research, the new statement of principles will sit alongside
this and is intended bring some consistency to the way government agencies
deal with IP in general contracts. This should make research consultancies,
in particular, less erratic to deal with. Agencies will be encouraged to
develop individual IP management frameworks based on the statement, but the
key message is that they will need to align their use of IP with their
objectives and activities. Other messages are that agencies need to consider
the benefit to the Australian community as a whole in managing IP; their
valuations of IP should not be used as the sole or principal justification
for commercialisation decisions; they should
provide training to staff so that they can more effectively handle the IP
rights of others ethically; and agencies should recognise
that the expertise to commercialise IP does not
necessarily lie within. A guidebook to implement the
statement, the IP Better Practice Manual, will be published later this year.
More information, including the full Statement of IP Principles can be found
at The Office
of Commercialisation website is now live! Visit us
at http://www.anu.edu.au/commercialisation/ |
||
|
PLEASE
CONTACT MELODY ELLIS IN THE OFFICE OF SPONSORED RESEARCH |
||